DPP-4 Inhibitors

GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

Empa PASS on Urinary Tract Malignancies

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Use of Incretins in Diabetic Patients

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

Incretin-based Drugs and Acute Pancreatitis

Incretin-based Drugs and the Risk of Heart Failure

Incretin-based Drugs and Pancreatic Cancer